BSL
Basilea Pharmace
Stock
Stock
ISIN: CH0011432447
Ticker: BSLN
CH0011432447
BSLN
Price
Price
CHART BY
Frequently asked questions
What is Basilea Pharmace's market capitalization?
The market capitalization of Basilea Pharmace is 799.78M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Basilea Pharmace's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Basilea Pharmace is 15.16. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Basilea Pharmace?
Basilea Pharmace's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.247. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Basilea Pharmace's stock?
Currently, 3 analysts cover Basilea Pharmace's stock, with a consensus target price of 87.70. Analyst ratings provide insights into the stock's expected performance.
What is Basilea Pharmace's revenue over the trailing twelve months?
Over the trailing twelve months, Basilea Pharmace reported a revenue of 247.42M.
What is the EBITDA for Basilea Pharmace?
Basilea Pharmace's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 63.64M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Basilea Pharmace?
Basilea Pharmace has a free cash flow of 55.30M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Basilea Pharmace have, and what sector and industry does it belong to?
Basilea Pharmace employs approximately 189 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Basilea Pharmace's shares?
The free float of Basilea Pharmace is 11.40M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 799.78M
- EPS (TTM)
- $4.247
- Free Float
- 11.40M
- P/E ratio (TTM)
- 15.16
- Revenue (TTM)
- 247.42M
- EBITDA (TTM)
- 63.64M
- Free Cashflow (TTM)
- 55.30M
Pricing
- 1D span
- $77.16$79.12
- 52W span
- $55.45$83.05
Analyst Ratings
The price target is 87.70 and the stock is covered by 3 analysts.
Buy
1
Hold
2
Sell
0
Information
Basilea Pharmaceutica AG engages in the discovery, development, and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000 and is headquartered in Allschwil, Switzerland.
- Employees
- 189
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- CH0011432447
- Primary Ticker
- BSLN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet